Veeva Systems Inc. VEEV

Company Overview

Veeva Systems Inc. is a cloud software company focused primarily on the global life sciences industry. The company develops industry-specific applications for pharmaceutical, biotechnology, medical device, and related healthcare organizations. Its software supports critical functions including clinical development, regulatory compliance, quality management, medical affairs, commercial operations, and data management. Veeva operates within the enterprise software, cloud computing, and healthcare technology sectors, with revenue primarily generated through subscription-based software services and related professional services.

The company’s principal business lines include the Veeva Commercial Solutions, Veeva Development Cloud, and Veeva Data Cloud product families. Its applications are widely used by large global pharmaceutical companies as well as emerging biotechnology firms. Veeva’s strategic positioning is built around deep specialization in regulated life sciences workflows, high switching costs due to compliance integration, and long-term customer relationships. Founded in 2007 by Peter Gassner and Matt Wallach, Veeva initially focused on customer relationship management applications for pharmaceutical sales teams built on Salesforce infrastructure. The company later expanded into clinical, regulatory, safety, quality, and data solutions, evolving into a broader cloud platform provider for life sciences organizations globally.

Business Operations

Veeva organizes operations primarily around two reportable segments: Veeva Commercial Solutions and Veeva R&D Solutions. Commercial Solutions includes customer relationship management applications, commercial content management, data products, and analytics tools used by sales and marketing organizations in life sciences companies. R&D Solutions encompasses clinical trial management, regulatory submissions, quality systems, safety monitoring, and related applications supporting drug development and compliance activities. The company generates most of its revenue from recurring subscription fees, supplemented by implementation, consulting, training, and support services.

The company operates internationally across North America, Europe, Asia-Pacific, and selected emerging markets. Veeva maintains strategic technology relationships, including a long-standing collaboration with Salesforce for portions of its CRM infrastructure, while also expanding proprietary platform capabilities through Veeva Vault, its cloud content management and application platform. Major subsidiaries include Veeva Systems UK Ltd., Veeva Systems Japan K.K., and other regional operating entities supporting localized compliance and customer delivery. Veeva has also developed partnerships with contract research organizations, pharmaceutical companies, and systems integrators to expand adoption of its software ecosystem across clinical and commercial operations.

Strategic Position & Investments

Veeva’s strategic direction centers on expanding its role as a vertically integrated cloud platform provider for the life sciences sector. The company has invested heavily in the expansion of the Veeva Vault platform, which serves as the foundation for many of its clinical, regulatory, and quality applications. Growth initiatives include increasing penetration among emerging biotechnology firms, expanding data and analytics offerings, and developing products that support decentralized clinical trials, regulatory digitization, and connected healthcare data environments. The company has also emphasized long-term recurring subscription growth and customer retention as core strategic priorities.

Veeva has pursued selective acquisitions and investments to strengthen specialized capabilities. Notable acquisitions include Crossix, which enhanced healthcare data analytics and patient intelligence capabilities, and CDB Solutions, which expanded clinical data management functionality. The company has also invested in artificial intelligence-enabled data applications and process automation technologies relevant to clinical research and commercial engagement workflows. Veeva’s industry-specific focus differentiates it from broader enterprise software providers by aligning products closely with regulatory and compliance requirements unique to life sciences organizations.

Geographic Footprint

Veeva Systems is headquartered in Pleasanton, California, and maintains operations across North America, Europe, Asia-Pacific, and parts of Latin America. The company serves many of the world’s largest pharmaceutical and biotechnology companies, including customers operating in highly regulated healthcare markets. Significant operational and customer concentration exists in the United States and Europe, though the company has expanded substantially in Japan, China, and other Asia-Pacific markets over the past decade.

The company maintains offices and operational hubs in countries including the United States, Canada, the United Kingdom, France, Germany, Switzerland, Japan, China, Singapore, and Australia. Its international footprint supports localized regulatory requirements and multilingual customer engagement. Veeva’s software platforms are used globally for drug development, regulatory filings, and commercial operations, giving the company influence across multiple stages of the pharmaceutical and biotechnology value chain.

Leadership & Governance

Veeva was co-founded by Peter Gassner and Matt Wallach, with Peter Gassner serving as a central figure in shaping the company’s product strategy and industry focus. The company emphasizes long-term customer success, industry specialization, and operational efficiency as core elements of its leadership philosophy. Veeva became a public company in 2013 and later adopted a public benefit corporation structure, reflecting a governance model intended to balance shareholder interests with customer, employee, and broader stakeholder considerations.

Key members of leadership include:

• Peter Gassner – Chief Executive Officer
• Matt Wallach – Co-Founder and former President
• Brennan Sellers – Chief Financial Officer
• Tom Schwenger – President and Chief Operating Officer
• Paul Shawah – Executive Vice President, Strategy
• Justin Kan – Executive Vice President, Product Management
• Marc Levine – Senior Vice President, Commercial Strategy

The company’s governance framework includes an independent board of directors and oversight practices consistent with U.S. public company reporting requirements. Leadership communications and strategic priorities are regularly outlined in SEC filings, annual reports, quarterly earnings materials, and investor presentations. Public disclosures consistently identify continued investment in product innovation, customer retention, and expansion within regulated healthcare industries as major operational priorities.